ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung - 1 ml
67995001 Lundbeck (Schweiz) AG
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung11.10.2021
  11.10.2021
Eptinezumab (N02CD05) 
WHO-DDD10.10.2026
02.05.10.1 ml
02.05.10. 
B  
Yes 
IP 
1141.21Yes
    
10 %1257.55
  
7680679950016Biotechnologika
  
Composition
eptinezumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 40.5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Eptinezumabum100 mg/ml
BAG: Active AgentDose
Eptinezumabum100 mg
 
Inactive agentsDose
Histidin Hydrochloride Monohydrate 
Histidine 
Polysorbatum 80 
Sorbitol40.5 mg/ml
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home